Home > Insider Trading > Filing (0001104659-22-092992)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1590750	Viridian Therapeutics Inc.	VRDN	Services-Medical Laboratories (8071)	471187261

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1686157	L.p. Fund Healthcare Fairmount	2001 Market Street Suite 2500 Philadelphia PA 19103	Yes	No	Yes	No
1769651	L.p. Ii Fund Healthcare Fairmount	2001 Market Street Suite 2500 Philadelphia PA 19103	Yes	No	Yes	No
1802528	Fairmount Funds Management Llc	200 Barr Harbor Drive Suite 400 West Conshohocken PA 19428	Yes	No	Yes	Yes
1830382	Fairmount Healthcare Fund Ii Gp Llc	2001 Market Street, Suite 2500 Philadelphia PA 19103	Yes	No	Yes	No
1830383	Fairmount Healthcare Fund Gp Llc	2001 Market Street, Suite 2500 Philadelphia PA 19103	Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-17	425,531	$23.50	1,363,764	No	4	P	Indirect	Fairmount Healthcare Fund II LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Fairmount Healthcare Fund II LP

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	5,859	Indirect	Fairmount Healthcare Fund LP

Footnotes

Fairmount Funds Management LLC and Fairmount Healthcare Fund GP LLC have voting power and investment power over the shares of Common Stock and Series A Non-Voting Convertible Preferred Stock held by Fairmount Healthcare Fund LP ("Fund I"). They disclaim beneficial ownership of securities held by Fund I for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.
Fairmount Funds Management LLC and Fairmount Healthcare Fund II GP LLC have voting power and investment power over the shares of Common Stock and Series A Non-Voting Convertible Preferred Stock held by Fairmount Healthcare Fund II LP ("Fund II"). They disclaim beneficial ownership of securities held by Fund II for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.